3. lab diagnostics Flashcards

(33 cards)

1
Q

pathology

A

study of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

aetiology

A

causation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

pathogenesis

A

progression of disease leading to effects on cells, tissues, and organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

potential causes of disease

A
  • pathogenic organisms
  • genetic mutations
  • epigenetic abnormalities
  • nutrient deficiencies
  • harmful environmental stimuli
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

molecular manifestations of disease

A

changes in protein
- expression
- structure
- function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

cellular manifestations of disease

A

changes in cell
- number
- morphology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

tissue/organ manifestations of disease

A

gross changes in
- structure
- function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

BCR-ABL kinase

A

novel protein
- promotes cell proliferation
- impairs DNA repair
- induces genomic instability
causes >90% of chronic myeloid leukaemia cases but found in other cancers too

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

aetiology of BCR-ABL kinase expression

A

chromosomal translocation between chromosomes 9 and 22 forming BCR-ABL fusion gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

pathogenesis of BCR-ABL kinase

A
  • hyperplasia
  • dysplasia
  • neoplasia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

diagnostic techniques investigate

A

potential changes associated with
- aetiology
- pathogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what is something that halts pcr extension

A

extension cannot continue through a primer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

DNA polymerase PCR cofactor

A

magnesium chloride

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

BCR-ABL treatment

A

targeted drug therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

BCR-ABL test

A

BCR pcr - control for primers
BCR-ABL pcr - test for fusion gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is the importance of controls

A

to ensure all protocols are functioning appropriately to give an accurate result

17
Q

importance of non-template control

A

to gauge whether contamination has taken place

18
Q

benefits of PCR multiplex to test for BCR-ABL

A

the BCR PCR can be used as a negative control

19
Q

what would a negative BCR-ABL test mean for a leukaemia patient

A

the BCR-ABL gene is not responsible for their leukaemia

20
Q

why are enzymes used for diagnostic IHC

A

they often don’t have the required microscope for fluorescent tag visualisation

21
Q

benefits of fluorescent tags for IHC

A

can put lots of tags on

22
Q

key stages of IHC

A
  • antigen retrieval
  • endogenous peroxidase deactivation
  • non-specific blocking
  • primary antibody
  • secondary antibody
  • substrate
23
Q

purpose of IHC

A

identify the expression of specific proteins in a tissue sample

24
Q

what principle does IHC rely on

A

all proteins are potential antigens detectable to the immune system so it is possible to generate an antibody that will bind to specific proteins.

25
how does detection work in IHC
the detection antibody often has an enzyme attached that can produce coloured product from substrate. this stains cells that are positive for target proteins.
26
CK7
cytokeratin 7 often expressed in adenocarcinomas of the breast
27
CK20
cytokeratin 20 most often present in colorectal cancer
28
IHC antigen retrieval
tissue sections are heated in a controlled environment to make sure that the antigens in the tissue are exposed for antibodies to bind to
29
IHC Endogenous peroxidase deactivation
blocking or impairment of endogenous peroxidases present in tissue to prevent them from converting the substrate into a coloured product
30
IHC non-specific blocking
non-specific proteins that may bind antigen-specific antibody are blocked, often with bovine serum albumin (BSA) or fetal calf serum (FCS)
31
IHC primary antibody
the antigen-specific antibody is added to the tissue and binds to any antigens that are present. unbound primary antibody is washed away
32
IHC secondary antibody
this is a detection antibody specific for the primary antibody, and often has an enzyme conjugated to it such as horseradish peroxidase (HRP). unbound is washed away
33
IHC substrate
a solution containing hydrogen peroxide and DAB chromagen is added. in the presence of HRP, these reagents produce a coloured product that will stain cells